December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

July 16, 2012

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

June 11, 2012

GlaxoSmithKline again has extended an unsolicited tender offer to acquire Human Genome Sciences.

June 4, 2012

One month after GlaxoSmithKline announced its tender offer to acquire Human Genome Sciences, HGS said Friday that its board of directors has rejected the unsolicited bid.

May 11, 2012

GlaxoSmithKline is moving forward with its acquisition of Human Genome Sciences.

April 25, 2012

GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.

November 16, 2010

A decision by a Food and Drug Administration advisory committee could pave the way for...

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

August 18, 2010

The Food and Drug Administration has decided to expedite the review of an investigational drug...

July 12, 2010

A developer of a new drug for treating lupus has entered a supply agreement with...

June 16, 2010

An investigational drug for lupus that could become the first new treatment for the disease...

June 9, 2010

Human Genome Sciences has submitted an approval application for a treatment for lupus, development partner...